TY - JOUR
T1 - Research on esophageal cancer
T2 - With personal perspectives from studies in China and Kenya
AU - Yang, Chung S.
AU - Chen, Xiaoxin Luke
N1 - Funding Information:
In 1980, supported by a grant from the US National Academy of Sciences, Chung S. Yang worked in Linxian with a collaborative group from the Henan Tumor Institute and Henan Medical College to measure blood levels of ascorbic acid and carotenoids and accessed riboflavin nutritional status by the glutathione reductase assay. The study confirmed the suspected lower nutritional status or insufficiency of vitamin C, pro‐vitamin A and riboflavin. With these results, the idea of a nutritional intervention study was discussed among collaborators in Linxian, Zhengzhou and Beijing, and then with Dr William Blot of the US National Cancer Institute (NCI). At that time, Dr Blot was visiting China and was interested in the idea. United States and China had recently established a formal diplomatic relationship, and the NCI was interested in establishing meaningful collaborative cancer research projects in China. In 1981, Dr Junyao Li, the chief epidemiologist from the CICAMS, was invited to the NCI to discuss US‐China collaboration on cancer research. The US‐China collaborative intervention studies would start a few years later. 9
Funding Information:
In China, most of the research activities on EC were historically centered in Linxian County (now named Linzhou City) of the Henan Province, located in the TMR. In this area, the EC mortality rate presented itself as concentric belts from a high incidence rate of >80/100 000 and descending to regions of >40, >20 and then <20/100 000. In August 1979, supported by a grant from the International Agency for Research on Cancer (IARC) and hosted by the Cancer Institute of the Chinese Academy of Medical Sciences (CICAMS) in Beijing, coauthor Chung S. Yang visited China to learn about EC research. Based on what he learned from Beijing and later in Linxian, Chung S. Yang wrote a review article titled “Research on Esophageal Cancer in China: A Review.” 3
Funding Information:
We would like to thank colleagues from China and Kenya who provided many of the information, and thank Vi Dan for her capable assistance in the preparation of this manuscript. The funding of the early work by Chung S. Yang was supported by International Agency for Research on Cancer and the US National Academy of Sciences. The Linxian Nutritional Intervention Studies was supported by a contract N01‐CP‐41019 from the National Cancer Institute to the CICAMS (subcontract to Chung S. Yang). The studies on molecular alterations of ESCC were supported by National Institutes of Health (NIH) grant CA65781 (to Chung S. Yang). Xiaoxin Luke Chen is supported by NIH grants (R01 CA244236, R21 AA028047, R01 DK113144, U54 MD012392, U54 AA019765, U54 CA156735).
Publisher Copyright:
© 2020 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.
PY - 2021/7/15
Y1 - 2021/7/15
N2 - The most common form of esophageal cancer (EC), esophageal squamous cell carcinoma (ESCC), is prevalent in many unindustrialized societies, among people with lower socioeconomic status and those who frequently use tobacco and alcohol. In some areas, ESCC mortality ranked top among all cancer. In this review, we begin with discussions of the extensive research on EC in Linxian in northern China that started 60 years ago and the recent studies in Kenya from our personal perspectives. Based on the results obtained from these studies and information from the literature, we summarize our current understanding about the risk factors for ESCC including lifestyle factors (smoking, alcohol, consumption of food and beverages at high temperature and other unhealthy habits), poor diet and nutritional insufficiencies and genetic susceptibility. Elimination or minimization of these environmental risk factors, as well as early detection and treatment of precancerous lesions, would be effective means for the prevention of ESCC. Current knowledge of molecular alterations in ESCC (gene mutations, hypermethylation and amplification or overexpression), as well as treatment of ESCC and the potential of targeted therapy, are also discussed. Finally, we propose effective approaches for the prevention of ESCC by adapting a healthy lifestyle, including a healthy diet that would also prevent other diseases. Community outreach, public education and international collaboration are important for achieving this public health goal.
AB - The most common form of esophageal cancer (EC), esophageal squamous cell carcinoma (ESCC), is prevalent in many unindustrialized societies, among people with lower socioeconomic status and those who frequently use tobacco and alcohol. In some areas, ESCC mortality ranked top among all cancer. In this review, we begin with discussions of the extensive research on EC in Linxian in northern China that started 60 years ago and the recent studies in Kenya from our personal perspectives. Based on the results obtained from these studies and information from the literature, we summarize our current understanding about the risk factors for ESCC including lifestyle factors (smoking, alcohol, consumption of food and beverages at high temperature and other unhealthy habits), poor diet and nutritional insufficiencies and genetic susceptibility. Elimination or minimization of these environmental risk factors, as well as early detection and treatment of precancerous lesions, would be effective means for the prevention of ESCC. Current knowledge of molecular alterations in ESCC (gene mutations, hypermethylation and amplification or overexpression), as well as treatment of ESCC and the potential of targeted therapy, are also discussed. Finally, we propose effective approaches for the prevention of ESCC by adapting a healthy lifestyle, including a healthy diet that would also prevent other diseases. Community outreach, public education and international collaboration are important for achieving this public health goal.
KW - esophageal cancer
KW - molecular alterations
KW - prevention
KW - risk factors
KW - therapy
UR - http://www.scopus.com/inward/record.url?scp=85097609225&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85097609225&partnerID=8YFLogxK
U2 - 10.1002/ijc.33421
DO - 10.1002/ijc.33421
M3 - Review article
C2 - 33270917
AN - SCOPUS:85097609225
SN - 0020-7136
VL - 149
SP - 264
EP - 276
JO - International Journal of Cancer
JF - International Journal of Cancer
IS - 2
ER -